Answers are grounded in this paper and cite their sources.
Background: Antioxidant, anti-inflammatory, and analgesic effects of mango stem bark extracts (MSBE) have been reported. A previous published report described the identification of several components (polyphenols, polyols, and sugars) by HPLC, MS, and NMR. Mangiferin (2-β-D-glucopyranosyl-1,3,6,7-tetrahydroxyl-9H- xanthen-9-one) was identified as the major bioactive component of MSBE. However, MSBE has shown more potent effects than model mangiferin solutions in several in vitro experiments at different concentrations. Therefore, there are other extract components which contribute to the observed pharmacological effects. Objective: The identification of other polyphenolic components in MSBE, which may contribute to the observed pharmacological effects through a synergic pathway. Method: Polyphenol-rich extracts from mango stem bark and branch trees from two varieties (Haden and Tommy Atkins), cultivated in Dominican Republic, were analyzed by HPLC-DAD. Butanol MSBE extract from Haden mango stem bark was analyzed by HPLC-MS-ESI. Results: The mangiferin content in Haden mango extracts by HPLC-DAD was considerably high as compared to previous reports in the literature from other mango varieties. The identification of Haden mango stem bark butanolic extract components by HPLC-ESI-MS led to the unambiguous identification of 20 components: 2 benzoic acid derivatives, gallic acid and 8 gallate derivatives, 2 benzophenones (maclaurin and iriflophenone types), 3 flavonoids (catechin, epicatechin, and quercetin), mangiferin, isomangiferin, homomangiferin, and noratyriol. Conclusion: HPLC-ESI-MS analysis of the Haden mango SB extract showed the presence of many polyphenolic components, not previously reported, which may correlate to the antioxidant, anti-inflammatory, and/or analgesic effects of this extract mostly through a synergistic effect of its components. The potential exploitation of mango by-products from the Haden variety would be the best option for obtaining polyphenol-rich extracts from mango agricultural by-products to be used as bioactive ingredients in nutraceutical, cosmeceutical, and/or pharmaceutical formulations.
No takes yet. Share an insight, caveat, or question.
Núñez‐Sellés et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: